Skip to main content
logo

Annual Conference 2019

March 28–31, 2019

Marriott City Center, Dallas, TX

Proposal authors of accepted papers can use the tool below (scroll down) to see where they have been placed in the agenda. Note: Special Topics sessions - Only the submitter's name is searchable, not panelists. [If you wish an overview of the conference please click here: Conference Overview Agenda.

Please use this search form to:

To see the full agenda, leave all drop-downs blank, and simply click on "Search." Please note that there are some options you may select once you have searched. (Please do not be confused about something that looks like "1.1 Digital Advertising" as this is simply a title of a group of sessions.

Contact the AAA Conference Office to accept the session assignment, or to request a change due to a conflict. Call (727) 940-2658 x 2004 if you have questions. Please be sure to reference the session title(s), date(s) and time(s) if you contact us.


7.3d The Role of Emotional and Cognitive Trust in Perceived Risk: Effects of Emotional and Functional Benefits in Direct-to-Consumer Prescription Drug Advertising

Sunday, March 31, 2019 at 8:30 AM–10:00 AM CDT
3-Bordeaux
Abstract

The influence of trust responses to advertising on perceived product risk has received little research attention despite established links between trust and risk perceptions in other fields. In addition, scholars have explored few message factors that can influence trust and perceived risk. This paper presents the results of an experiment conducted within the context of prescription drug advertising to address these gaps. Benefit type (functional versus emotional) and amount of risk information were manipulated while involvement with the health condition served as a measured variable. Results indicated an emotional benefits message increased positive trust feelings (security) which in turn decreased perceived drug risk among those with higher involvement while the functional benefits message reduced perceived drug risk via ad credibility among those with lower involvement. These results were only seen when the amount of risk was high and the health condition was not life-threatening. 

First & Corresponding Author

Jennifer Ball, Temple University
Authors in the order to be printed.

Jennifer Ball, Temple University

Additional Authors

Loading…